ProShares - Large Cap Core Plus
$87.62−0.72 (−0.81%)
- Expense ratio
- 0.45%
- Fund size
- $527M
- 1Y return
- +16.5%
- Yield · Last 12 months
- 1.01%
- Holdings
- 313
- Volume · 30D
- 0M sh
- NAV per share
- $88.66
- 52W range
The ETF.net CSM Grade
Score 56 of 100 sits in the B band. Bands: A ≥ 70, B ≥ 55, C ≥ 40, D ≥ 25, F < 25; the scale skips E.
Cost
What you pay to own it — the expense ratio plus trading frictions, ranked within its category.DScore 28Category rankMission
How faithfully it does the job it claims — tracking its mandate or index with minimal slippage.AScore 97Category rankRisk
How violently it can move — volatility, drawdown depth, and downside capture versus its category.BScore 58Category rankTradability
How cheaply and easily you can get in and out — liquidity, spread, and premium/discount stability.CScore 44Category rankHoldings
What it actually owns — the quality, breadth, and concentration of the underlying portfolio.CScore 46Category rankDurability
Whether it will still be here — the fund’s assets, age, flows, and issuer staying power.AScore 70Category rank
Our read on CSM
BA survivor of the 2009 130/30 craze. CSM runs 130% long a four-factor screen of big U.S. companies and 30% short, so net exposure lands near the market while the factor tilts get turned up.
The Fund seeks pre-expense investment results that track the UBS 130/30 Index. It uses equity securities and derivatives to maintain exposure to a rules-based, multi-factor portfolio of leading large-cap U.S. companies with 130% long and 30% short exposure.
Why people hold it
- The shorting is the whole point: 130% long, 30% short. Net exposure sits near 100% of the market, but the factor bets carry more weight than a long-only screen allows.
- Four factors in one rulebook (value, growth, momentum, profitability) spread across roughly 300 large U.S. companies, so no single style is steering the whole portfolio.proshares.com
- Long-short mechanics inside an ordinary 1940 Act ETF: no lockups, no accreditation, no K-1. It tracks a published benchmark, the UBS 130/30 Index, rather than a manager's hunches.
- Trading since 2009, which is a long run for a long-short strategy. Most of the 130/30 wave that launched alongside it did not last. Distributions come quarterly.
Worth knowing
- 0.45% a year is toward the high end for large-cap multifactor. Plain-vanilla peers like VONV (0.06%) and IUSG (0.04%) cost a fraction, though neither shorts anything.
- One of the lighter-traded funds in its category, which can mean wider bid-ask spreads than the volume leaders in large-cap factor land.
- The short sleeve cuts both ways: it adds borrow and derivative costs, and it drags when the market's lowest-ranked names are the ones running.
CSM Holdings
- Stocks
- 313
- 33%
- NVDA
Sectors
- Technology30.8%
- Financials17.4%
- Health Care9.3%
- Industrials9.2%
- Consumer Discr.8.2%
- Communication7.3%
- Cons. Staples4.8%
- Real Estate3.9%
- Utilities3.7%
- Energy3.2%
- Materials2.3%
Geography
- United States98.01%
- Ireland1.01%
- Bermuda0.25%
- United Kingdom0.23%
- Switzerland0.22%
- Netherlands0.21%
- Singapore0.06%
CSM Performance
Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.
Returns run to the Sep 22, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.
| Period | CSM |
|---|---|
| Year to date | +11.7% |
| 1 month | −0.1% |
| 3 months | +4.0% |
| 1 year | +16.5% |
| 3 years | +23.0% |
| 5 years | +12.9% |
| 10 years | +14.2% |
Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.
| Year | Return bar | CSM |
|---|---|---|
| 2026 YTD | +11.7% | |
| 2025 | +21.8% | |
| 2024 | +22.1% | |
| 2023 | +23.5% | |
| 2022 | −18.3% | |
| 2021 | +33.1% | |
| 2020 | +11.0% |
CSM in the news
ETF.net Research hasn’t filed on CSM yet — coverage lands here as it’s written.
CSM Dividends
- 1.01%
- $0.90
- $0.23 per share
- Quarterly
Distribution history
| Ex-date | Pay date | Amount per share |
|---|---|---|
| Jun 24, 2026 | Jun 30, 2026 | $0.23 |
| Mar 25, 2026 | Mar 31, 2026 | $0.21 |
| Dec 24, 2025 | Dec 31, 2025 | $0.26 |
| Sep 24, 2025 | Sep 30, 2025 | $0.20 |
| Jun 25, 2025 | Jul 1, 2025 | $0.20 |
| Mar 26, 2025 | Apr 1, 2025 | $0.17 |
| Dec 23, 2024 | Dec 31, 2024 | $0.22 |
| Sep 25, 2024 | Oct 2, 2024 | $0.16 |
| Jun 26, 2024 | Jul 3, 2024 | $0.17 |
| Mar 20, 2024 | Mar 27, 2024 | $0.15 |
| Dec 20, 2023 | Dec 28, 2023 | $0.21 |
| Sep 20, 2023 | Sep 27, 2023 | $0.14 |
CSM Risk
- 13.2%
How it’s calculated: standard deviation
The sample standard deviation of monthly total returns, multiplied by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.
- 1.18
How it’s calculated: Sharpe ratio
Subtract each month’s Treasury-bill return from the fund’s monthly total return.
Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.
- −23.8%
How it’s calculated: maximum drawdown
The largest percentage decline from an earlier peak, using total returns with reinvested distributions.
Uses up to five years through the last close, with at least 12 months required.
- 0.99
How it’s calculated: beta
The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.
CSM Cost
- The middle half of US Multifactor funds
- Median 0.30%
69 of the 98 US Multifactor funds charge less.